Atlas Trials

GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.

Clinical trial NCT05562518 · COMPLETED

Trial details

NCT number
NCT05562518
Sponsor
University Hospital, Ghent
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Vulvovaginal AtrophyBreast Cancer
Start date
2022-03-21
Primary completion
2026-03-02
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.